Major US Formulary Change Triggers, but Does Not Sustain, Increases in Biosimilar Adalimumab Prescribing.

Arthritis care & research

2026

https://researcherprofiles.org/profile/754170939

41693624

Roberts ET, Schmajuk G, Clark M, Ung D, Yazdany J